Vaccination Strategies Against Highly Variable Pathogens
Lars Hangartner · Dennis R. Burton
سبتمبر 2020 · Current Topics in Microbiology and Immunology الكتاب 428 · Springer Nature
كتاب إلكتروني
180
صفحة
reportلم يتم التحقّق من التقييمات والمراجعات. مزيد من المعلومات
معلومات عن هذا الكتاب الإلكتروني
Vaccines against antigenically stable pathogens, or pathogens that only exist in a limited number of serotypes, have been very successful in the past and have drastically decreased the incidence and lethality of many diseases. However, when it comes to highly variable pathogens or viruses that exist in multiple serotypes, the traditional methods for vaccine development have reached their limits.
This volume highlights the development of vaccines against such challenging pathogens. Novel approaches for immunogen design, including structure-guided vaccine development and vaccines targeting glycans, as well as adjuvants and animal models used for testing possible vaccine candidates are outlined and discussed in detail. Given its scope, the book will appeal to scientists in the fields of infectious diseases, microbiology and medicine.
This volume highlights the development of vaccines against such challenging pathogens. Novel approaches for immunogen design, including structure-guided vaccine development and vaccines targeting glycans, as well as adjuvants and animal models used for testing possible vaccine candidates are outlined and discussed in detail. Given its scope, the book will appeal to scientists in the fields of infectious diseases, microbiology and medicine.
نبذة عن المؤلف
Lars Hangartner, Ph.D.
Lars Hangartner is a molecular biologist and immunologist whose research focuses on the humoral response against variable pathogens, such as influenza A virus and HIV. Moreover, he has performed basic studies on measles virus and lymphocytic choriomeningitis virus. He is currently an associate professor at the Scripps Research Institute in La Jolla, California, and his present research investigates Fc/FcγR interactions as well as epitope mapping of polyclonal antibody response in the context of HIV vaccine development.
Dennis R. Burton, Ph.D.
Dennis Burton is the Chair and Professor in the Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA and James and Jessie Minor Chair in Immunology. He is the Scientific Director of the IAVI Neutralizing Antibody Center, Director of The Consortium for HIV/AIDS Vaccine Development (CHAVD) at Scripps, and a member of the Ragon Institute of MGH, MIT and Harvard, Boston, USA. His research is focused on infectious disease, in particular the interplay of antibodies and highly mutable viruses, notably HIV. He is interested in the potential of broadly neutralizing antibodies to inform vaccine design.
Lars Hangartner is a molecular biologist and immunologist whose research focuses on the humoral response against variable pathogens, such as influenza A virus and HIV. Moreover, he has performed basic studies on measles virus and lymphocytic choriomeningitis virus. He is currently an associate professor at the Scripps Research Institute in La Jolla, California, and his present research investigates Fc/FcγR interactions as well as epitope mapping of polyclonal antibody response in the context of HIV vaccine development.
Dennis R. Burton, Ph.D.
Dennis Burton is the Chair and Professor in the Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California, USA and James and Jessie Minor Chair in Immunology. He is the Scientific Director of the IAVI Neutralizing Antibody Center, Director of The Consortium for HIV/AIDS Vaccine Development (CHAVD) at Scripps, and a member of the Ragon Institute of MGH, MIT and Harvard, Boston, USA. His research is focused on infectious disease, in particular the interplay of antibodies and highly mutable viruses, notably HIV. He is interested in the potential of broadly neutralizing antibodies to inform vaccine design.
تقييم هذا الكتاب الإلكتروني
أخبرنا ما هو رأيك.
معلومات القراءة
الهواتف الذكية والأجهزة اللوحية
ينبغي تثبيت تطبيق كتب Google Play لنظام التشغيل Android وiPad/iPhone. يعمل هذا التطبيق على إجراء مزامنة تلقائية مع حسابك ويتيح لك القراءة أثناء الاتصال بالإنترنت أو بلا اتصال بالإنترنت أينما كنت.
أجهزة الكمبيوتر المحمول وأجهزة الكمبيوتر
يمكنك الاستماع إلى الكتب المسموعة التي تم شراؤها على Google Play باستخدام متصفح الويب على جهاز الكمبيوتر.
أجهزة القراءة الإلكترونية والأجهزة الأخرى
للقراءة على أجهزة الحبر الإلكتروني، مثل أجهزة القارئ الإلكتروني Kobo، عليك تنزيل ملف ونقله إلى جهازك. يُرجى اتّباع التعليمات المفصّلة في مركز المساعدة لتتمكّن من نقل الملفات إلى أجهزة القارئ الإلكتروني المتوافقة.
